Clinical Trial Update: Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing early effects of abaloparatide on tissue-based indices of bone formation and resorption in osteoporosis, with completed status an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Osteoporosis Age-related
• Osteoporosis Fracture
• Osteoporosis Localized to Spine
• Osteoporosis Postmenopausal
• Osteoporosis Risk
• Osteoporosis Senile
• Osteoporosis Vertebral
• Osteoporosis of Vertebrae

Drugs mentioned

• Abaloparatide (abaloparatide)

Snippet

Sponsor: Radius Health, Inc. | Conditions: Osteoporosis, Postmenopausal, Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2021-10-15